Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
ClinicalTrials.gov study NCT01968109. IPD Sharing: Not stated. Countries: 15. Publications: 4.
Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
ClinicalTrials.gov study NCT03085719. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04649476. IPD Sharing: NO. Countries: 1. Publications: 2.
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
ClinicalTrials.gov study NCT01096602. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy
ClinicalTrials.gov study NCT03904108. IPD Sharing: NO. Countries: 1. Publications: 24.
PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer
ClinicalTrials.gov study NCT03179410. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
ClinicalTrials.gov study NCT00141297. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT02999477. IPD Sharing: NO. Countries: 1. Publications: 2.
Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC
ClinicalTrials.gov study NCT03274804. IPD Sharing: NO. Countries: 1. Publications: 1.
Motor Training in PD
ClinicalTrials.gov study NCT02457832. IPD Sharing: NO. Countries: 1. Publications: 3.
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
ClinicalTrials.gov study NCT02041533. IPD Sharing: Not stated. Countries: 26. Publications: 2.
Fixed-Dose Trial in Early Parkinson's Disease (PD)
ClinicalTrials.gov study NCT04201093. IPD Sharing: NO. Countries: 12. Publications: 0.
PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03155425. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa
ClinicalTrials.gov study NCT03881371. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Atomoxetine PBPK-PD Clinical Study
ClinicalTrials.gov study NCT03154359. IPD Sharing: UNDECIDED. Countries: 1. Publications: 10.
Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia
ClinicalTrials.gov study NCT04364269. IPD Sharing: NO. Countries: 5. Publications: 1.
Light Therapy for PD - Dose Selection
ClinicalTrials.gov study NCT04291014. IPD Sharing: NO. Countries: 1. Publications: 7.
Effects of Vitamin D in Parkinson's Disease (PD)
ClinicalTrials.gov study NCT01119131. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT03202875. IPD Sharing: YES. Countries: 1. Publications: 1.
Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.
ClinicalTrials.gov study NCT04483219. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.